July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018

Morphology of the Neuroretina in Multiple System Atrophy:
does the Pathology of MSA manifest in the retina?
Author Affiliations & Notes
  • Kathrin Kaehler
    Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Tyrol, Austria
  • Hartwig Seitter
    Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Tyrol, Austria
  • Adolf Sandbichler
    Zoology, University of Innsbruck, Innsbruck, Austria
  • Gerald Obermair
    Physiology and Medical Physics, Innsbruck Medical University, Innsbruck, Austria
  • Nadia Stefanova
    Neurology, Innsbruck Medical University, Innsbruck, Austria
  • Alexandra Koschak
    Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Tyrol, Austria
  • Footnotes
    Commercial Relationships   Kathrin Kaehler, None; Hartwig Seitter, None; Adolf Sandbichler, None; Gerald Obermair, None; Nadia Stefanova, None; Alexandra Koschak, None
  • Footnotes
    Support  FWF austrian Science fund (P26881, AK; F4414, NS), University of Innsbruck, Center of Molecular Biosciences (CMBI)
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1884. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kathrin Kaehler, Hartwig Seitter, Adolf Sandbichler, Gerald Obermair, Nadia Stefanova, Alexandra Koschak;
      Morphology of the Neuroretina in Multiple System Atrophy:
      does the Pathology of MSA manifest in the retina?. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1884.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Due to the reported physiological and morphological abnormalities in central neurons in Parkinson's disease and Multiple System Atrophy (MSA), neurodegenerative diseases that are also associated with a variety of visual symptoms, homozygous transgenic mice overexpressing human α-SYN under the proteolipid protein (PLP)-promoter (PLP-α-SYN) were used to study morphological implications of the retina in MSA.

Methods : Immunohistochemistry was performed to investigate the expression of several relevant proteins in retinal tissue.

Results : Distinct α-SYN signal occurred in different retinal cell layers of PLP-α-SYN, but not WT mice. This is remarkable as the PLP promotor driving the α-SYN expression in oligodendrocytes was reported to be inactive in the retina. PLP expression stopped at the optic nerve/retina junction, where we observed a colocalization with α-SYN. Notably there was one cell type distinctly stained in the central, but even more in the peripheral inner retina that was identified to be rod bipolar cells. These neurons are involved in conveying the visual information to RGCs that were also investigated by retinal wholemount stainings to test whether the overall number of RGCs is preserved. Increased glial fibrillary acidic protein (GFAP) signals in the peripheral PLP-α-SYN retina also indicated neuroinflammatory processes.

Conclusions : Our findings implicate an impairment of retinal neurons in the PLP-α-SYN MSA model which may also underlie visual deficits reported in MSA patients.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×